BBIO (STOCKS)
BridgeBio Pharma, Inc. Common Stock
$76.320000
+1.730000 (+2.32%)
Prev close: $74.590000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Neil Kumar
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $15,094.17M
- Employees
- 730
- P/E (TTM)
- -20.58
- P/B (TTM)
- -7.27
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $502.08M |
| Benefits Costs and Expenses | $1.23B |
| Cost Of Revenue | $20.96M |
| Costs And Expenses | $1.03B |
| Gross Profit | $481.11M |
| Nonoperating Income/Loss | -$209.09M |
| Operating Expenses | $1.00B |
| Selling, General, and Administrative Expenses | $531.23M |
| Research and Development | $451.95M |
| Other Operating Expenses | $21.35M |
| Operating Income/Loss | -$523.41M |
| Income/Loss Before Equity Method Investments | -$659.90M |
| Income/Loss From Continuing Operations After Tax | -$732.94M |
| Income/Loss From Continuing Operations Before Tax | -$732.50M |
| Income/Loss From Equity Method Investments | -$72.61M |
| Income Tax Expense/Benefit | $435.00K |
| Income Tax Expense/Benefit, Current | $435.00K |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$732.94M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$8.01M |
| Net Income/Loss Attributable To Parent | -$724.93M |
| Net Income/Loss Available To Common Stockholders, Basic | -$724.93M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.78 |
| Diluted Earnings Per Share | -$3.78 |
| Basic Average Shares | 191,527,482 |
| Diluted Average Shares | 191,527,482 |
| Assets | $936.03M |
| Current Assets | $797.75M |
| Inventory | $26.75M |
| Other Current Assets | $771.00M |
| Noncurrent Assets | $138.28M |
| Fixed Assets | $5.37M |
| Intangible Assets | $28.08M |
| Other Non-current Assets | $104.83M |
| Liabilities | $3.01B |
| Current Liabilities | $287.97M |
| Accounts Payable | $36.23M |
| Wages | $76.70M |
| Other Current Liabilities | $175.04M |
| Noncurrent Liabilities | $2.72B |
| Long-term Debt | $2.01B |
| Other Non-current Liabilities | $717.30M |
| Redeemable Noncontrolling Interest | -$570.00K |
| Equity | -$2.08B |
| Equity Attributable To Noncontrolling Interest | $10.60M |
| Equity Attributable To Parent | -$2.09B |
| Temporary Equity | -$570.00K |
| Liabilities And Equity | $936.03M |
| Net Cash Flow From Operating Activities | -$445.91M |
| Net Cash Flow From Operating Activities, Continuing | -$445.91M |
| Net Cash Flow From Investing Activities | -$24.49M |
| Net Cash Flow From Investing Activities, Continuing | -$24.49M |
| Net Cash Flow From Financing Activities | $359.29M |
| Net Cash Flow From Financing Activities, Continuing | $359.29M |
| Net Cash Flow | -$111.10M |
| Net Cash Flow, Continuing | -$111.10M |
| Comprehensive Income/Loss | -$732.93M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$8.01M |
| Comprehensive Income/Loss Attributable To Parent | -$724.93M |
| Other Comprehensive Income/Loss | $4.00K |